Vascular changes in tumours after treatment with ICRF 159.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001808:Blood Vessels / Q000187:drug effects*; D002277:Carcinoma / Q000150:complications; D002296:Carcinosarcoma / Q000150:complications; D007659:Ketones / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000150:complications; D051379:Mice; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000473:pathology; D010690:Phlebography; D010879:Piperazines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D007659:Ketones; D010879:Piperazines